U.S. Wound Care Centers Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

The U.S. wound care centers market was valued at USD 13 billion in 2019 and is expected to grow at a CCAGR of around 3.7% from forecast period 2020 to 2027.

The increasing prevalence of chronic injuries in the geriatric population and the growing demand for outpatient services is expected to drive the growth of the market during the forecast period. In addition, the growing adoption of new technologies such as hyperbaric oxygen therapy for treating non-healing and chronic injuries is expected to result in an increased demand for wound care centers in the U.S.

Effective outcomes with the use of hyperbaric oxygen therapy for chronic injuries such as diabetic foot ulcers and arterial ulcers are expected to aid the high demand for hyperbaric oxygen therapy from physicians.

Wound care centers provide care for various types of injuries, debridement of injuries with infections, HBOT for non-healing and chronic injuries, and specialized dressings. The centers are taking measures to make HBOT available to their patients, considering its effectiveness in healing chronic and non-chronic injuries.

The Hyperbaric Oxygen Therapy (HBOT) segment dominated the U.S. wound care centers market and held the largest market share of 30.1% in 2019. The segment is followed by debridement and specialized dressing procedures, in terms of revenue share.

Some of the prominent players include:

  • Baptist Health South Florida

  • TOWER WOUND CARE CENTER

  • SNF Wound Care

  • Wound Care Center NYC

  • WOUND INSTITUTE OF AMERICA

  • EmergeOrtho

  • North Shore Health and Hyperbarics

  • Natchitoches Regional Medical Center

  • Schoolcraft Memorial Hospital

  • Clarion Hospital

  • Healogics, Inc.

Market Segmentation

Procedure Outlook

  • Debridement

  • Negative pressure wound therapy

  • Compression therapy

  • Hyperbaric oxygen therapy

  • Specialized dressings

  • Infection control and Others

Report Detail

Proceed To Buy

USD 3500
USD 6000